Expression of HS6ST1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

HS6ST1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 50.42

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

37.7

Number of samples

141

Samples

Sample	Description	TPM
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	94.1
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	85.3
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	79.0
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	72.6
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	71.4
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	69.7
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	68.8
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	67.1
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	66.1
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	65.9
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	65.4
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	65.2
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	62.6
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	62.2
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	61.0
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	60.7
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	60.1
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	59.1
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	58.7
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	58.7
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	56.5
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	56.3
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	56.2
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	55.7
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	53.9
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	53.5
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	53.3
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	53.2
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	52.6
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	51.6
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	51.5
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	50.8
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	50.0
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	49.7
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	49.1
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	48.8
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	48.7
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	48.4
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	48.0
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	47.4
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	46.7
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	46.5
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	45.9
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	44.1
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	43.7
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	42.6
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	41.8
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	41.0
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	40.6
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	40.4
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	40.3
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	40.2
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	40.2
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	39.7
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	39.7
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	39.5
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	39.5
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	39.1
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	38.8
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	38.6
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	38.3
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	38.1
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	38.1
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	37.5
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	37.4
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	37.3
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	37.2
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	37.0
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	37.0
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	35.6
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	35.6
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	34.8
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	34.7
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	34.6
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	34.4
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	34.1
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	33.7
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	33.6
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	33.1
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	32.8
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	32.8
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	32.3
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	31.7
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	31.5
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	31.5
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	31.3
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	31.3
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	30.8
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	30.5
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	30.2
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	29.5
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	29.1
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	29.1
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	28.8
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	28.7
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	28.4
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	28.3
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	27.8
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	27.7
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	27.1
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	26.8
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	25.6
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	25.5
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	25.5
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	25.4
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	25.4
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	25.0
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	24.9
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	24.2
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	24.2
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	23.9
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	23.5
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	23.2
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	22.7
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	22.6
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	22.6
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	22.4
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	22.4
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	22.2
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	21.4
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	20.6
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	20.6
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	20.3
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	19.6
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	16.8
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	16.6
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	15.6
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	15.6
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	15.5
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	15.1
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	15.1
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	14.8
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	13.7
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	13.1
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	12.1
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	11.8
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	11.3
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	11.0
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	10.8
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	10.0
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	9.5
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

HS6ST1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 10.3

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

9.1

Number of samples

Samples

Sample	Description	TPM
AK139	N, NA, stage:NA, dead, 270 days	27.1
AK074	N, NA, stage:NA, alive, 300 days	18.4
AK053	N, NA, stage:NA, dead, 300 days	17.9
AK236	N, NA, stage:NA, dead, 360 days	17.6
AK205	N, NA, stage:NA, dead, 120 days	16.6
AK227	N, NA, stage:NA, alive, 300 days	15.0
AK098	N, NA, stage:NA, dead, 660 days	13.5
AK158	N, NA, stage:NA, dead, 360 days	13.4
AK213	N, NA, stage:NA, alive, 2010 days	13.2
AK071	N, NA, stage:NA, dead, 540 days	12.8
AK117	N, NA, stage:NA, dead, 210 days	12.8
AK035	N, NA, stage:NA, dead, 210 days	12.6
AK091	N, NA, stage:NA, dead, 210 days	12.5
AK100	N, NA, stage:NA, alive, 960 days	12.2
AK089	N, NA, stage:NA, dead, 330 days	11.3
AK072	N, NA, stage:NA, dead, 150 days	10.8
AK123	N, NA, stage:NA, dead, 180 days	10.5
AK178	N, NA, stage:NA, dead, 240 days	10.4
AK185	N, NA, stage:NA, alive, 330 days	10.2
AK068	N, NA, stage:NA, alive, 360 days	9.7
AK153	N, NA, stage:NA, dead, 240 days	9.5
AK226	N, NA, stage:NA, dead, 360 days	9.4
AK188	N, NA, stage:NA, alive, 420 days	9.3
AK167	N, NA, stage:NA, dead, 180 days	9.2
AK015	N, NA, stage:NA, alive, 720 days	9.2
AK055	N, NA, stage:NA, dead, 240 days	9.0
AK134	N, NA, stage:NA, dead, 360 days	8.9
AK165	N, NA, stage:NA, alive, 360 days	8.9
AK183	N, NA, stage:NA, alive, 360 days	8.8
AK043	N, NA, stage:NA, alive, 660 days	8.8
AK051	N, NA, stage:NA, dead, 360 days	8.7
AK041	N, NA, stage:NA, alive, 810 days	8.3
AK218	N, NA, stage:NA, dead, 180 days	8.2
AK030	N, NA, stage:NA, dead, 120 days	7.5
AK006	N, NA, stage:NA, dead, 360 days	7.3
AK099	N, NA, stage:NA, dead, 420 days	7.2
AK173	N, NA, stage:NA, dead, 180 days	7.1
AK216	N, NA, stage:NA, dead, 360 days	7.0
AK124	N, NA, stage:NA, alive, 1920 days	7.0
AK133	N, NA, stage:NA, dead, 360 days	6.7
AK199	N, NA, stage:NA, alive, 1860 days	6.6
AK231	N, NA, stage:NA, dead, 240 days	6.6
AK005	N, NA, stage:NA, dead, 240 days	6.5
AK085	N, NA, stage:NA, alive, 660 days	6.1
AK088	N, NA, stage:NA, dead, 360 days	5.9
AK076	N, NA, stage:NA, alive, 660 days	5.8
AK149	N, NA, stage:NA, dead, 420 days	5.6
AK003	N, NA, stage:NA, dead, 600 days	5.3
AK066	N, NA, stage:NA, alive, 960 days	5.3
AK079	N, NA, stage:NA, dead, 210 days	4.9
AK049	N, NA, stage:NA, dead, 180 days	4.5
AK195	N, NA, stage:NA, dead, 390 days	4.2
AK103	N, NA, stage:NA, alive, 1320 days	4.0
AK081	N, NA, stage:NA, dead, 180 days	4.0
AK142	N, NA, stage:NA, alive, 90 days	3.4
AK156	N, NA, stage:NA, dead, 330 days	3.4
AK002	N, NA, stage:NA, dead, 570 days	3.2
AK102	N, NA, stage:NA, alive, 1740 days	3.1
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0168080003	Tumor	1.7
CPT0123530003	Tumor	1.3
CPT0190360004	Tumor	0.8
CPT0204370003	Normal	0.8
CPT0204360003	Normal	0.8
CPT0204350003	Normal	0.7
CPT0093450003	Tumor	0.7
CPT0204340003	Normal	0.7
CPT0204380003	Normal	0.7
CPT0217000004	Tumor	0.6
CPT0087730003	Tumor	0.6
CPT0217100003	Tumor	0.5
CPT0189750004	Tumor	0.4
CPT0167970003	Tumor	0.4
CPT0206880003	Tumor	0.3
CPT0218690004	Tumor	0.3
CPT0218770003	Tumor	0.3
CPT0171580008	Tumor	0.3
CPT0092440003	Tumor	0.3
CPT0205450004	Tumor	0.3
CPT0093510003	Tumor	0.3
CPT0204330003	Normal	0.3
CPT0168830003	Tumor	0.3
CPT0093590003	Tumor	0.3
CPT0218670003	Tumor	0.3
CPT0162100003	Tumor	0.3
CPT0204410003	Normal	0.3
CPT0205570003	Tumor	0.3
CPT0189460003	Tumor	0.3
CPT0209440003	Tumor	0.2
CPT0204400003	Normal	0.2
CPT0064890003	Tumor	0.2
CPT0206110003	Tumor	0.2
CPT0206230003	Tumor	0.2
CPT0204390003	Normal	0.2
CPT0206330003	Tumor	0.2
CPT0204420003	Normal	0.2
CPT0205890003	Tumor	0.2
CPT0218330004	Tumor	0.2
CPT0182500003	Tumor	0.2
CPT0078580003	Tumor	0.2
CPT0217190003	Tumor	0.2
CPT0079790003	Tumor	0.2
CPT0168270003	Tumor	0.1
CPT0189570004	Tumor	0.1
CPT0127480003	Tumor	0.1
CPT0205670004	Tumor	0.1
CPT0162140003	Tumor	0.1
CPT0190240004	Tumor	0.1
CPT0189250003	Tumor	0.1
CPT0218830004	Tumor	0.1
CPT0199770003	Tumor	0.1
CPT0186100003	Tumor	0.1
CPT0224330003	Tumor	0.1
CPT0189850004	Tumor	0.1
CPT0087950003	Tumor	0.1
CPT0167530003	Tumor	0.0
CPT0196850003	Tumor	0.0
CPT0217880003	Tumor	0.0
CPT0093360003	Tumor	0.0
CPT0225730003	Tumor	0.0
CPT0224390004	Tumor	0.0
CPT0208980003	Tumor	0.0
CPT0167750004	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0167860004	Tumor	-0.1
CPT0087680003	Tumor	-0.1
CPT0225760003	Tumor	-0.1
CPT0162020003	Tumor	-0.1
CPT0168380003	Tumor	-0.1
CPT0104330003	Tumor	-0.1
CPT0217060003	Tumor	-0.1
CPT0168590003	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0224540004	Tumor	-0.2
CPT0206780003	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0201710003	Tumor	-0.2
CPT0206670004	Tumor	-0.2
CPT0224600003	Tumor	-0.2
CPT0206450003	Tumor	-0.2
CPT0125510003	Tumor	-0.2
CPT0206000004	Tumor	-0.2
CPT0167640003	Tumor	-0.2
CPT0207030003	Tumor	-0.2
CPT0093550003	Tumor	-0.2
CPT0175060003	Tumor	-0.3
CPT0207090003	Tumor	-0.3
CPT0089150003	Tumor	-0.3
CPT0205780003	Tumor	-0.3
CPT0161730003	Tumor	-0.3
CPT0125570003	Tumor	-0.3
CPT0125220003	Tumor	-0.3
CPT0182580003	Tumor	-0.3
CPT0104220003	Tumor	-0.4
CPT0217710008	Tumor	-0.4
CPT0219080004	Tumor	-0.4
CPT0071100003	Tumor	-0.5
CPT0218960004	Tumor	-0.5
CPT0168480003	Tumor	-0.5
CPT0217430008	Tumor	-0.6
CPT0002410011	Tumor	-0.6
CPT0216920008	Tumor	-0.6
CPT0228220003	Tumor	-0.6
CPT0189650004	Tumor	-0.6
CPT0182550003	Tumor	-0.6
CPT0206560003	Tumor	-0.6
CPT0127420003	Tumor	-0.7
CPT0221180003	Tumor	-0.7
CPT0087570003	Tumor	-1.0
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis